Novel drug discovery strategies for the treatment of decompensated cirrhosis-Reference-Cited by-同舟云学术

Novel drug discovery strategies for the treatment of decompensated cirrhosis

Published:2021-12-31 Issue: Volume: Page:1-10
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Lamatsch Sven¹,Sittner Richard¹,Tacke Frank¹,Engelmann Cornelius¹²³^ORCID

Affiliation:

1. Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany

2. Berlin Institute of Health at Charité (BIH) - BIH Biomedical Innovation Academy, Berlin, Germany

3. Institute for Liver and Digestive Health, University College London, London, UK

Funder

Berlin Institute of Health

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2020755

Reference98 articles.

1. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

3. Acute-on-Chronic Liver Failure

4. Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure

5. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebertransplantation bei akutem und akut-auf-chronischem Leberversagen;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2024-07-23